Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 34% ± 13% | |
| pericyte | 12 studies | 51% ± 20% | |
| glutamatergic neuron | 7 studies | 38% ± 18% | |
| GABAergic neuron | 7 studies | 40% ± 20% | |
| interneuron | 6 studies | 37% ± 12% | |
| retina horizontal cell | 6 studies | 47% ± 19% | |
| retinal bipolar neuron | 5 studies | 52% ± 26% | |
| macrophage | 5 studies | 22% ± 5% | |
| smooth muscle cell | 5 studies | 32% ± 8% | |
| podocyte | 4 studies | 51% ± 25% | |
| neuron | 4 studies | 28% ± 6% | |
| type I pneumocyte | 4 studies | 23% ± 4% | |
| fibroblast | 4 studies | 25% ± 10% | |
| GABAergic interneuron | 3 studies | 31% ± 11% | |
| retinal cone cell | 3 studies | 42% ± 16% | |
| ON-bipolar cell | 3 studies | 67% ± 26% | |
| rod bipolar cell | 3 studies | 64% ± 19% | |
| endothelial cell of vascular tree | 3 studies | 23% ± 4% | |
| platelet | 3 studies | 23% ± 0% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 40% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 550.72 | 2411 / 2642 | 96% | 13.86 | 680 / 705 |
| kidney | 100% | 1450.44 | 89 / 89 | 85% | 18.84 | 769 / 901 |
| thymus | 100% | 1754.94 | 652 / 653 | 83% | 85.07 | 505 / 605 |
| adrenal gland | 99% | 1363.77 | 255 / 258 | 73% | 10.60 | 167 / 230 |
| breast | 100% | 1743.38 | 459 / 459 | 43% | 4.19 | 476 / 1118 |
| intestine | 99% | 1216.26 | 960 / 966 | 41% | 2.73 | 218 / 527 |
| skin | 80% | 598.81 | 1439 / 1809 | 48% | 4.37 | 226 / 472 |
| bladder | 100% | 1191.43 | 21 / 21 | 22% | 1.54 | 110 / 504 |
| prostate | 98% | 721.21 | 239 / 245 | 20% | 0.81 | 99 / 502 |
| uterus | 99% | 747.47 | 168 / 170 | 15% | 1.14 | 69 / 459 |
| stomach | 73% | 538.00 | 263 / 359 | 31% | 2.22 | 89 / 286 |
| lung | 91% | 608.69 | 524 / 578 | 13% | 0.80 | 150 / 1155 |
| adipose | 100% | 2128.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| heart | 100% | 2642.68 | 861 / 861 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2822.20 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 99% | 1068.30 | 238 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 71% | 774.56 | 1027 / 1445 | 20% | 1.18 | 37 / 183 |
| blood vessel | 88% | 618.81 | 1179 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 53% | 280.32 | 96 / 180 | 31% | 2.01 | 134 / 430 |
| pancreas | 27% | 96.90 | 88 / 328 | 39% | 2.09 | 69 / 178 |
| eye | 0% | 0 | 0 / 0 | 21% | 1.19 | 17 / 80 |
| peripheral blood | 17% | 71.59 | 155 / 929 | 0% | 0 | 0 / 0 |
| liver | 1% | 2.42 | 2 / 226 | 14% | 1.83 | 57 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 1.13 | 4 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.39 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031032 | Biological process | actomyosin structure organization |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0016020 | Cellular component | membrane |
| GO_0008092 | Molecular function | cytoskeletal protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FRMD3 |
| Protein name | FERM domain containing 3 FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O) |
| Synonyms | EPB41L4O |
| Description | FUNCTION: Putative tumor suppressor gene that may be implicated in the origin and progression of lung cancer. . |
| Accessions | ENST00000376434.5 [A2A2Y4-3] A2A2Y4 ENST00000304195.8 [A2A2Y4-1] Q5JV61 ENST00000376438.5 [A2A2Y4-2] ENST00000328788.5 [A2A2Y4-4] ENST00000621208.4 [A2A2Y4-5] ENST00000431299.1 |